Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Biohit Oyj's Diagnostic Starts Large China Gastric Cancer Screening Study

publication date: Jul 17, 2015
A giant gastric cancer screening study, which will test at least 20,000 people in 50 hospitals, has started in China, using the GastroPanel test developed by Finland's Biohit Oyj. The goal is early detection of gastric cancer, a prevalent form of cancer in China. One year ago, Biohit Oyj formed a JV with Anhui Wisdom-Win Investment Co. to make and distribute the GastroPanel in China. More details....

Stock Symbol: (HEL: BIOBV)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here